ESR1 and neoplasm: While paclitaxel significantly inhibited the tumor growth of the WT-ER group (Fig. 3b, p < 0.0001), resistance to paclitaxel was noted in the D538G mice group, and they formed larger tumors compared to WT-ER (Fig. 3b, p < 0.05).